Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test.

Public health genomics - 1 Jan 2020

Hamilton Jada G, Genoff Garzon Margaux, Shah Ibrahim H, Cadet Kechna, Shuk Elyse, Westerman Joy S, Hay Jennifer L, Offit Kenneth, Robson Mark E

Abstract excerpt

INTRODUCTION: Genetic risk modifier testing (GRMT), an emerging form of genetic testing based on common single nucleotide polymorphisms and polygenic risk scores, has the potential to refine estimates of BRCA1/2 mutation carriers' breast cancer risks. However, for women to benefit from GRMT, effective approaches for communicating this novel risk information are needed. OBJECTIVE: To evaluate patient preferences...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Genetic Carrier Screening

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic factors in colorectal cancer

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Genomics and Rare Diseases

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 32191943
DOI: 10.1159/000505854
PMCID: PMC7272266

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test.PMID 32191943Read ↗

Exploring communication preferences for disclosing breast cancer risk in women with a family history.Semantic proximity Read ↗

The Breast Cancer Genetic Testing Experience: Probing the Potential Utility of an Online Decision Aid in Risk Perception and Decision MakingSemantic proximity Read ↗

Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.Semantic proximity Read ↗

The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making.Semantic proximity Read ↗

Assessing the acceptability and appropriateness of a psychoeducational graphic novel about inherited cancer risk designed for men.Semantic proximity Read ↗

Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation.Semantic proximity Read ↗

Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations.Semantic proximity Read ↗

Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age.Semantic proximity Read ↗

BRCAShare-Assessment of an animated digital message for intrafamilial communication of pathogenic variant positive test results: A feasibility study.Semantic proximity Read ↗

The co-design, development, and preliminary evaluation of a comprehensive breast cancer risk report incorporating polygenic risk informationSemantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.Semantic proximity Read ↗

Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.